$231.48
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Country

US

CEO

Mr. Michael Farrell

IPO date

1995

Employees

10,600

ISIN

US7611521078

Key stats

Open

$229.44

Volume

1.73M

Market cap

$33.40B

Prev. close

$231.52

Impl / hst vl

-

Open interest

$0.00

$228.53

Day’s Range

$234.14

$180.27

52W Range

$277.67

Valuation

55
Valuation score
Fairly Valued
P/E
21.47
P/S
5.79
P/B
4.97
Current ratio
3.10
Debt / Equity
0.10
ROE
23.88%
Gross margin
58.84%
Income growth
-3.84%
FCF growth
-22.77

Sep

24

Dividends

The last payment date was Sep 24, 2026

Div. per Share

$0.66

Div. Yield

0.29%

Payout Ratio

-

Div. Growth YoY

10.00%

Analysts estimates

Consensus rating
Hold

The average rating from top 11 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$253.54
The top 17 analysts forecasts that 12-month price may increase by 9.53%, with a low of $181.80 and a high of $341.25
$181.80
Low
$253.54
Avg
$341.25
High
Current price

Earnings

Q2 ‘26 revenue
$1.46B
Q2 ‘26 net income
$383.43M
Revenue
Net income
Previous EPS
$2.81
Estimate EPS
$2.82
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply